1 | rheumatoid | 3,061 |
2 | irritable | 780 |
3 | ankylosing | 507 |
4 | psoriatic | 436 |
5 | endoplasmic | 378 |
6 | amyotrophic | 302 |
7 | sarcoplasmic | 192 |
8 | thrombocytopenic | 171 |
9 | gouty | 116 |
10 | collagen-induced | 89 |
11 | adjuvant-induced | 43 |
12 | plasmic | 30 |
13 | henoch-schönlein | 23 |
14 | sarcoplasmic/endoplasmic | 8 |
15 | sarco/endoplasmic | 7 |
16 | anti-mag | 6 |
17 | henoch-schonlein | 5 |
18 | sarcoendoplasmic | 5 |
19 | cricoarytenoid | 4 |
20 | endocellular | 4 |
21 | paraprotein-associated | 4 |
22 | rebel | 4 |
23 | 1/sarcoplasmic | 3 |
24 | cytopenic | 3 |
25 | endoplasmatic | 3 |
26 | hydrop | 3 |
27 | pax6+ | 3 |
28 | post-step | 3 |
29 | site-inhibited | 3 |
30 | tricompartmental | 3 |
31 | amyotropic | 2 |
32 | anti-gouty | 2 |
33 | contra- | 2 |
34 | cxr-defined | 2 |
35 | enteropathic | 2 |
36 | formaldehyde-induced | 2 |
37 | fuzhuan | 2 |
38 | interapophyseal | 2 |
39 | left-knee | 2 |
40 | mcmaster-toronto | 2 |
41 | nano-oligosaccharide | 2 |
42 | non-rheumatoid | 2 |
43 | osteomyelitis/septic | 2 |
44 | precolonoscopic | 2 |
45 | psoriasis/psoriatic | 2 |
46 | schonlein | 2 |
47 | spondyloarthritis/ankylosing | 2 |
48 | 'alopecia | 1 |
49 | 'glucosamine/chondroitin | 1 |
50 | 'rheumatoid | 1 |
51 | -irritable | 1 |
52 | 1.5-2-mm | 1 |
53 | 3.3+/-0.9 | 1 |
54 | auto-allergic | 1 |
55 | base-lv | 1 |
56 | bundles-the | 1 |
57 | collagen-adjuvant | 1 |
58 | complete-type | 1 |
59 | distolateral | 1 |
60 | end-circulation | 1 |
61 | endoplasmic/sarcoplasmic | 1 |
62 | enthesitis-related | 1 |
63 | epidermal-growth | 1 |
64 | er/sarcoplasmic | 1 |
65 | iba-induced | 1 |
66 | idio-pathic | 1 |
67 | immunothrombocytopenic | 1 |
68 | l2/3-l2/3 | 1 |
69 | methyloversatilis | 1 |
70 | mid/4 | 1 |
71 | myc-associated | 1 |
72 | non-irritable | 1 |
73 | non-nap | 1 |
74 | p10-p14 | 1 |
75 | phospholamban-sarcoplasmic/endoplasmic | 1 |
76 | post-treatment/post-observation | 1 |
77 | preparations-poor | 1 |
78 | pristane-induced | 1 |
79 | program/small | 1 |
80 | radiographically-confirmed | 1 |
81 | rapid-psoriatic | 1 |
82 | reumathoid | 1 |
83 | rheumathoid | 1 |
84 | rheumatoicd | 1 |
85 | rheumatoidal | 1 |
86 | rheumatology-rheumatoid | 1 |
87 | rv-focused | 1 |
88 | s.apiospermum-induced | 1 |
89 | sarco-/endoplasmic | 1 |
90 | sarcoplasmic-endoplasmic | 1 |
91 | schönlein | 1 |
92 | supra-physiologic | 1 |
93 | syndrome/reactive | 1 |
94 | thrombocytopaenic | 1 |
95 | tmev-induced | 1 |
96 | ttc-stained | 1 |
97 | zigoapophysary | 1 |
98 | ≤4/week | 1 |
1 | 'alopecia | 1 |
2 | 'glucosamine/chondroitin | 1 |
3 | 'rheumatoid | 1 |
4 | -irritable | 1 |
5 | 1.5-2-mm | 1 |
6 | 1/sarcoplasmic | 3 |
7 | 3.3+/-0.9 | 1 |
8 | adjuvant-induced | 43 |
9 | amyotrophic | 302 |
10 | amyotropic | 2 |
11 | ankylosing | 507 |
12 | anti-gouty | 2 |
13 | anti-mag | 6 |
14 | auto-allergic | 1 |
15 | base-lv | 1 |
16 | bundles-the | 1 |
17 | collagen-adjuvant | 1 |
18 | collagen-induced | 89 |
19 | complete-type | 1 |
20 | contra- | 2 |
21 | cricoarytenoid | 4 |
22 | cxr-defined | 2 |
23 | cytopenic | 3 |
24 | distolateral | 1 |
25 | end-circulation | 1 |
26 | endocellular | 4 |
27 | endoplasmatic | 3 |
28 | endoplasmic | 378 |
29 | endoplasmic/sarcoplasmic | 1 |
30 | enteropathic | 2 |
31 | enthesitis-related | 1 |
32 | epidermal-growth | 1 |
33 | er/sarcoplasmic | 1 |
34 | formaldehyde-induced | 2 |
35 | fuzhuan | 2 |
36 | gouty | 116 |
37 | henoch-schonlein | 5 |
38 | henoch-schönlein | 23 |
39 | hydrop | 3 |
40 | iba-induced | 1 |
41 | idio-pathic | 1 |
42 | immunothrombocytopenic | 1 |
43 | interapophyseal | 2 |
44 | irritable | 780 |
45 | l2/3-l2/3 | 1 |
46 | left-knee | 2 |
47 | mcmaster-toronto | 2 |
48 | methyloversatilis | 1 |
49 | mid/4 | 1 |
50 | myc-associated | 1 |
51 | nano-oligosaccharide | 2 |
52 | non-irritable | 1 |
53 | non-nap | 1 |
54 | non-rheumatoid | 2 |
55 | osteomyelitis/septic | 2 |
56 | p10-p14 | 1 |
57 | paraprotein-associated | 4 |
58 | pax6+ | 3 |
59 | phospholamban-sarcoplasmic/endoplasmic | 1 |
60 | plasmic | 30 |
61 | post-step | 3 |
62 | post-treatment/post-observation | 1 |
63 | precolonoscopic | 2 |
64 | preparations-poor | 1 |
65 | pristane-induced | 1 |
66 | program/small | 1 |
67 | psoriasis/psoriatic | 2 |
68 | psoriatic | 436 |
69 | radiographically-confirmed | 1 |
70 | rapid-psoriatic | 1 |
71 | rebel | 4 |
72 | reumathoid | 1 |
73 | rheumathoid | 1 |
74 | rheumatoicd | 1 |
75 | rheumatoid | 3,061 |
76 | rheumatoidal | 1 |
77 | rheumatology-rheumatoid | 1 |
78 | rv-focused | 1 |
79 | s.apiospermum-induced | 1 |
80 | sarco-/endoplasmic | 1 |
81 | sarco/endoplasmic | 7 |
82 | sarcoendoplasmic | 5 |
83 | sarcoplasmic | 192 |
84 | sarcoplasmic-endoplasmic | 1 |
85 | sarcoplasmic/endoplasmic | 8 |
86 | schonlein | 2 |
87 | schönlein | 1 |
88 | site-inhibited | 3 |
89 | spondyloarthritis/ankylosing | 2 |
90 | supra-physiologic | 1 |
91 | syndrome/reactive | 1 |
92 | thrombocytopaenic | 1 |
93 | thrombocytopenic | 171 |
94 | tmev-induced | 1 |
95 | tricompartmental | 3 |
96 | ttc-stained | 1 |
97 | zigoapophysary | 1 |
98 | ≤4/week | 1 |
1 | pax6+ | 3 |
2 | contra- | 2 |
3 | l2/3-l2/3 | 1 |
4 | mid/4 | 1 |
5 | p10-p14 | 1 |
6 | 3.3+/-0.9 | 1 |
7 | 'alopecia | 1 |
8 | supra-physiologic | 1 |
9 | auto-allergic | 1 |
10 | amyotrophic | 302 |
11 | idio-pathic | 1 |
12 | enteropathic | 2 |
13 | plasmic | 30 |
14 | sarcoplasmic | 192 |
15 | 1/sarcoplasmic | 3 |
16 | endoplasmic/sarcoplasmic | 1 |
17 | er/sarcoplasmic | 1 |
18 | endoplasmic | 378 |
19 | sarcoplasmic-endoplasmic | 1 |
20 | sarco-/endoplasmic | 1 |
21 | sarcoplasmic/endoplasmic | 8 |
22 | phospholamban-sarcoplasmic/endoplasmic | 1 |
23 | sarco/endoplasmic | 7 |
24 | sarcoendoplasmic | 5 |
25 | thrombocytopaenic | 1 |
26 | cytopenic | 3 |
27 | thrombocytopenic | 171 |
28 | immunothrombocytopenic | 1 |
29 | precolonoscopic | 2 |
30 | amyotropic | 2 |
31 | psoriatic | 436 |
32 | rapid-psoriatic | 1 |
33 | psoriasis/psoriatic | 2 |
34 | endoplasmatic | 3 |
35 | osteomyelitis/septic | 2 |
36 | rheumatoicd | 1 |
37 | iba-induced | 1 |
38 | formaldehyde-induced | 2 |
39 | pristane-induced | 1 |
40 | s.apiospermum-induced | 1 |
41 | collagen-induced | 89 |
42 | adjuvant-induced | 43 |
43 | tmev-induced | 1 |
44 | radiographically-confirmed | 1 |
45 | ttc-stained | 1 |
46 | cxr-defined | 2 |
47 | rv-focused | 1 |
48 | myc-associated | 1 |
49 | paraprotein-associated | 4 |
50 | enthesitis-related | 1 |
51 | site-inhibited | 3 |
52 | rheumathoid | 1 |
53 | reumathoid | 1 |
54 | cricoarytenoid | 4 |
55 | rheumatoid | 3,061 |
56 | 'rheumatoid | 1 |
57 | non-rheumatoid | 2 |
58 | rheumatology-rheumatoid | 1 |
59 | nano-oligosaccharide | 2 |
60 | left-knee | 2 |
61 | bundles-the | 1 |
62 | irritable | 780 |
63 | -irritable | 1 |
64 | non-irritable | 1 |
65 | complete-type | 1 |
66 | syndrome/reactive | 1 |
67 | anti-mag | 6 |
68 | ankylosing | 507 |
69 | spondyloarthritis/ankylosing | 2 |
70 | epidermal-growth | 1 |
71 | ≤4/week | 1 |
72 | rheumatoidal | 1 |
73 | interapophyseal | 2 |
74 | distolateral | 1 |
75 | tricompartmental | 3 |
76 | rebel | 4 |
77 | program/small | 1 |
78 | 1.5-2-mm | 1 |
79 | fuzhuan | 2 |
80 | schonlein | 2 |
81 | henoch-schonlein | 5 |
82 | schönlein | 1 |
83 | henoch-schönlein | 23 |
84 | 'glucosamine/chondroitin | 1 |
85 | end-circulation | 1 |
86 | post-treatment/post-observation | 1 |
87 | mcmaster-toronto | 2 |
88 | non-nap | 1 |
89 | post-step | 3 |
90 | hydrop | 3 |
91 | endocellular | 4 |
92 | preparations-poor | 1 |
93 | methyloversatilis | 1 |
94 | collagen-adjuvant | 1 |
95 | base-lv | 1 |
96 | zigoapophysary | 1 |
97 | gouty | 116 |
98 | anti-gouty | 2 |